These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6855795)

  • 1. Human lymphocytes/freeze-dried microsomes. An improved method for short-term mutagenesis and carcinogenesis testing.
    Dolfini E; Villa P; Raffini A; Fuhrman Conti AM
    Mutat Res; 1983 Jun; 120(4):277-80. PubMed ID: 6855795
    [No Abstract]   [Full Text] [Related]  

  • 2. Basic requirements for in vitro metabolic activation systems in mutagenesis testing.
    Wood AW; Bartsch H; Fishbein L; Garattini S; Gielen J; Malaveille C; Roberfroid M; Teichman B; Vesell E
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):277-94. PubMed ID: 6935183
    [No Abstract]   [Full Text] [Related]  

  • 3. Activation of cyclophosphamide by freeze-dried microsomes as an in vitro test of cytogenetic damage.
    Dolfini E; Larizza L; Villa P; Fuhrman Conti AM
    Mutat Res; 1982 Dec; 105(6):429-32. PubMed ID: 7155162
    [No Abstract]   [Full Text] [Related]  

  • 4. Short-term tests for transplacentally active carcinogens. Induction of sister-chromatid exchanges in foetal brain, lung and blood-forming cells by procarbazine and cyclophosphamide.
    Henderson L; Cole RJ; Whittaker J; Regan T; Cole H
    Mutat Res; 1983 Oct; 113(6):489-98. PubMed ID: 6621579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenesis assays with mammalian cells.
    Kuroki T; Abbondandolo A; Drevon C; Huberman E; Laval F
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):107-33. PubMed ID: 6935177
    [No Abstract]   [Full Text] [Related]  

  • 6. Binding of concanavalin-A to critical-point-dried and freeze-dried human lymphocytes.
    Schneider GB; Pockwinse SM; Billings-Gagliardi S
    Am J Anat; 1979 Sep; 156(1):121-9. PubMed ID: 517445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Environmental mutagenesis and carcinogenesis: test method development, validation and utilization.
    de Serres FJ; Matsushima T
    Mutat Res; 1984 Oct; 130(5):353-9. PubMed ID: 6493256
    [No Abstract]   [Full Text] [Related]  

  • 8. Mutagenesis assays with bacteria.
    Davis A; Devoret R; Green M; Hofnung M; Kawachi T; Matsushima T; McCann J; Mohn GR; Norpoth K; Radman M; Rosenkranz HS; Venitt S
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):85-106. PubMed ID: 6450174
    [No Abstract]   [Full Text] [Related]  

  • 9. International Commission for Protection against Environmental Mutagens and Carcinogens. Committee 2 Final Report. Mutagenesis testing as an approach to carcinogenesis.
    Mutat Res; 1982 Jul; 99(1):73-91. PubMed ID: 6214712
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of SCE test in human lymphocytes and Vicia faba: a hopeful technique using plants to detect mutagens and carcinogens.
    Xing WJ; Zhang ZL
    Mutat Res; 1990 Jun; 241(2):109-13. PubMed ID: 2345549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the metabolizing systems for short-term genotoxicity assays: a review.
    Paolini M; Cantelli-Forti G
    Mutat Res; 1997 Aug; 387(1):17-34. PubMed ID: 9254890
    [No Abstract]   [Full Text] [Related]  

  • 12. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC publication No. 16. Testing for mutagens and carcinogens; the role of short-term genotoxicity assays.
    Mutat Res; 1988; 205(1-4):3-12. PubMed ID: 3285192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational decision points in carcinogenicity bioassays based on mechanisms of mutagenesis and carcinogenesis.
    Weisburger JH; Williams GM
    Prog Clin Biol Res; 1986; 209B():91-8. PubMed ID: 3749111
    [No Abstract]   [Full Text] [Related]  

  • 14. Surface coats on human lymphocytes: freeze-drying and staining with cations.
    Billings-Gagliardi S; Pockwinse SM; Schneider GB
    Am J Anat; 1979 Feb; 154(2):267-76. PubMed ID: 83794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of pretreatment with cytochrome P-450 inducers and preincubation with a cytochrome P-450 effector on the mutagenicity of genotoxic carcinogens mediated by hepatic and renal S9 from two species of marine fish.
    Guobaitis RJ; Ellingham TJ; Maddock MB
    Mutat Res; 1986 Feb; 164(1):59-70. PubMed ID: 3512989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro testing of chlorpropamide with human lymphocyte cultures in the presence of liver microsome fraction S9 mix of rats.
    Basler A; Baumann M; Röhrborn G
    Arzneimittelforschung; 1982; 32(7):724-6. PubMed ID: 6889871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term tests for defining mutagenic carcinogens.
    Waters MD; Stack HF; Jackson MA
    IARC Sci Publ; 1999; (146):499-536. PubMed ID: 10353401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term and short-term screening assays for carcinogens: a critical appraisal.
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):1-426. PubMed ID: 6935176
    [No Abstract]   [Full Text] [Related]  

  • 19. Bacterial and mammalian mutagenicity tests: validation and comparative studies on 180 chemicals.
    Bartsch H; Malaveille C; Camus AM; Martel-Planche G; Brun G; Hautefeuille A; Sabadie N; Barbin A; Kuroki T; Drevon C; Piccoli C; Montesano R
    IARC Sci Publ; 1980; (27):179-241. PubMed ID: 7002778
    [No Abstract]   [Full Text] [Related]  

  • 20. The monitoring of environmental mutagens/carcinogens. A perspective on tests predicting chemical mutagens/carcinogens in man.
    Anderson D
    Ecol Dis; 1982; 1(1):59-73. PubMed ID: 6765300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.